Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Given Consensus Rating of “Buy” by Brokerages
Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) have received a consensus recommendation of “Buy” ...